Market Overview
The Global Chondroitin Sulfate Market is estimated to reach at a CAGR of 5% during the forecast period (2024-2031).
Chondroitin sulfate is a sulfated glycosaminoglycan (GAG) composed of a chain of alternating sugars like N-acetylgalactosamine and glucuronic acid. It is a natural chemical component of human connective tissues that are generally found in cartilage around bone joints in the human body. Chondroitin sulfate is generally manufactured from the animal source, such as bovine, porcine, shark and other marine sources. Chondroitin sulfate is an alternative medicine for slowing the progression of osteoarthritis.
Market Scope
| Metrics | Details |
| Market CAGR | 5% |
| Segments Covered | By Source, By Application, By Distribution Channel, and By Region |
| Report Insights Covered | Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other key insights. |
| Fastest Growing Region | Asia Pacific |
| Largest Market Share | North America |
To Get a Free Sample Click here
Market Dynamics and Trends
The global chondroitin sulfate market growth is driven by the rising awareness towards joint health and the introduction of novel chondroitin sulfate combination products.
Increasing demand for nutraceutical products is expected to drive growth in the forecast period
Sodium chondroitin sulfate is used in dietary supplements and food products as thickeners, additives, forming agents, preservatives, in health food, and in animal feed. It is extensively used due to its ability to treat pets suffering from joint pain and arthritis, including diseases such as chronic pain and aches from osteoarthritis, elbow dysplasia, and hip dysplasia. Food grade and animal feed grade applications are presumed to drive the market growth in the forecast period.
It is also used to improve digestive function, enhance liver function, lower blood sugar, and inhibit tumor metastasis. The growing popularity of its use in the treatment of osteoarthritis and several other treatments is expected to benefit the overall market growth.
Growth in the pharmaceutical and personal care industry is expected to drive the market growth
Growth in the pharmaceutical and personal care industry owing to changing lifestyles and increasing healthcare expenditure may foster the product demand. The rising application of chondroitin sulfate in medicines is to cure joint pain and inflammation, which may drive the overall market growth. Growth in the personal care industry owing to increasing personal care expenditure may drive the product market size. The product is used in skin and hair repair creams and lotions owing to its ability to moisturize, heal and soothe skin. Chondroitin sulfate is also used in skincare products owing to its benefits such as anti-inflammatory properties and skin’s intercellular matrix reinforcement ability, thereby stimulating the product demand.
Regulatory obstruction is likely to hinder the market growth
However, religious & cultural impediments on the usage of chondroitin sulfate (Middle Eastern countries) are a few of the factors restricting the growth of the global chondroitin sulfate market.
COVID-19 Impact Analysis on Chondroitin Sulfate Market
The COVID-19 pandemic has emerged as a humanitarian as well as economic crisis, creating strain on society and affecting millions of people and businesses. Due to the diversion of the medical field towards treating COVID-19, the funding to R&D activities related to chondroitin sulfate has been reduced and this segment has to face negligence subsequently causing a negative impact on chondroitin sulfate market. Continuous monitoring for emerging signs of a possible new world order post-COVID-19 crisis is a must for aspiring businesses and their astute leaders seeking to find success in the now changing chondroitin sulfate market landscape.
Market Segmentation Analysis
The pharmaceuticals segment is expected to grow at the fastest CAGR during the forecast period (2024-2031)
Chondroitin sulfate is majorly used for the treatment of osteoarthritis. It is often used in combination with other ingredients such as glucosamine sulfate, manganese ascorbate, N-acetyl glucosamine or glucosamine hydrochloride. Chondroitin sulfate is also taken orally for heart attack, HIV/AIDS, heart disease, osteoporosis, joint pains because of the drugs used in the treatment of breast cancer, high cholesterol, muscle soreness after exercise, acid reflux, interstitial cystitis, Kashin-Beck disease, and psoriasis.
Chondroitin sulfate is approved by the FDA as an eye drops to treat dry eyes and is also used as a solution to preserve cornea during cataract surgery. In 2017, Imprimis Pharmaceuticals Inc., an ophthalmology-focused pharmaceutical company, announced that it has entered into a licensing agreement for the exclusive worldwide rights to Klarity, ophthalmic topical solution, and gel technology for patients with a dry eye disease (DED).
Chondroitin sulfate ointments in combination with glucosamine sulfate, shark cartilage, and camphor can be used for the pain of osteoarthritis. Some patients will inject chondroitin sulfate into muscles for osteoarthritis and some will insert chondroitin sulfate into the bladder for urinary tract infections, bladder conditions, or loss of bladder control. Thus there is a wide range of medicinal applications of chondroitin sulfate, the respective segment is expected to grow significantly.
The hospital pharmacy is expected to dominate the chondroitin sulfate market during the forecast period
The hospital pharmacies held the largest share in the chondroitin sulfate market. This is mainly owing to the increasing number of patients suffering from conditions that are treated in hospitals equipped with advanced infrastructure and adequate facilities. Moreover, the growing number of hospitals along with adequate reimbursement policies is also contributing to the growth of this segment.
Market Geographical Share
North America region holds the largest market share global chondroitin sulfate market
The well-established pharmaceutical industry in the North America region and increasing USFDA approvals for chondroitin sulfate will drive the growth of the chondroitin sulfate market in the region.
The increased use of osteoarthritis in cataract surgery and formulations for a drop in the eye are also a few factors that are enhancing the growth of the market in North America. In November 2017, Gnosis launched the first dietary supplements with Mythocondro, the unique 100% vegan chondroitin sulfate similar to human synovial fluid into the USA market. Furthermore, increasing demand for anti-ageing products is likely to further propel regional industry growth. The population of elderly people is expected to surpass over 173 million by 2026, which are more prone to orthopedic diseases. Chondroitin sulfate is used to cure orthopedic diseases like osteoporosis and osteoarthritis, which may boost the regional product demand.
Market Companies and Competitive Landscape
The chondroitin sulfate market is moderately competitive with the presence of local as well as global companies. Some of the key players which are contributing to the growth of the market include are FIDIA FARMACEUTICI S.P.A, GNOSIS S.p.A., Merck KGaA (Sigma-Aldrich, Inc), Synutra, Inc., Summit Nutritionals International, Nutramax Laboratories Inc., Bioiberica S.A.U, Pacific Rainbow International, Yantai Ruikangda Biochemical Products Co., Ltd., TSI Group Ltd among others. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the chondroitin sulfate market globally.
Market Key Companies to Watch
Pacific Rainbow Inc
Overview: Pacific Rainbow International Inc, which was established in 1995 in California, is a supplier in Chondroitin Sulfate (90% for any testing methods), Glucosamine Hcl /Sulfate, MSM, DHEA, Biotin, Inostitol Nicotinate Alpha Lipoic Acid etc. The international first-class Heparin Sodium and Chondroitin sulphate Workshops are completely complying with GMP which ensure that our product quality ranking is in the leading position in this line. Our effective access to raw materials.
Product Portfolio: The Company’s portfolio is comprised of wholesale distribution of paints, varnishes, wallpaper, and supplies.
Why Purchase the Report?
- Visualize the composition of the chondroitin sulfate market segmentation by source, application, distribution channel, and region highlighting the key commercial assets and players.
- Identify commercial opportunities in the chondroitin sulfate market by analyzing trends and co-development deals.
- Excel data sheet with thousands of data points of chondroitin sulfate market-level 4/5 segmentation.
- PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
- Product mapping in excel for the key product of all major market players
The global chondroitin sulfate market report would provide an access to an approximately 45+ market data table, 40+ figures and 180 pages.
Target Audience
- Service Providers/ Buyers
- Industry Investors/Investment Bankers
- Education & Research Institutes
- Research Professionals
- Emerging Companies
- Manufacturers
